ROQUEFORT THERAPEUTICS PLC
Biotechnology company developing medicines for therapy-resistant cancers.
ROQ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMDQ2T15
- LEI:
- 254900P4SISIWOR9RH34
- Country:
- United Kingdom
- Address:
- 85 Great Portland Street, W1W 7LT London
- Website:
- https://www.roquefortplc.com/
Description
Roquefort Therapeutics PLC is a biotechnology company focused on developing next-generation, first-in-class medicines for hard-to-treat cancers. The company operates within the high-growth immuno-oncology market. Its portfolio consists of five novel, patent-protected, pre-clinical anti-cancer programs. These programs are designed to target cancers that have become resistant to existing therapies. Roquefort Therapeutics utilizes a distributed R&D model, combining its in-house expertise and laboratory facilities with a network of partnerships with leading academic cancer research centers to advance its development strategy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-06 08:00 |
Notice of Annual General Meeting
|
English | 12.3 KB | ||
| 2023-06-05 13:17 |
Annual Report & Financial Statements
|
English | 1.9 MB | ||
| 2023-06-05 08:00 |
Annual Report & Financial Statements - 31 Dec 2022
|
English | 645.6 KB | ||
| 2023-05-02 08:56 |
Suspension of Trading Pending 2022 Annual Report
|
English | 14.0 KB | ||
| 2023-03-13 08:30 |
Confirmation of No Exposure to Silicon Valley Bank
|
English | 11.4 KB | ||
| 2023-03-08 08:00 |
Creation of New Novel Family of mRNA Therapeutics
|
English | 15.2 KB | ||
| 2023-03-06 08:00 |
Formation of Scientific Advisory Board
|
English | 19.2 KB | ||
| 2023-03-01 08:00 |
Company Presentation
|
English | 12.0 KB | ||
| 2023-02-21 08:00 |
Investor Presentation
|
English | 13.1 KB | ||
| 2023-02-20 08:00 |
Randox Licence and Royalty Agreement
|
English | 16.3 KB | ||
| 2023-01-24 08:00 |
MDK Oncology Antibodies Demonstrate In-Vivo Safety
|
English | 15.0 KB | ||
| 2023-01-18 09:36 |
Holding(s) in Company
|
English | 51.6 KB | ||
| 2023-01-16 08:00 |
Appointment of Auditor
|
English | 12.1 KB | ||
| 2023-01-09 08:00 |
Operations Update
|
English | 18.5 KB | ||
| 2022-12-05 09:07 |
Presentation of Midkine Oligonucleotide Program
|
English | 12.9 KB |
Automate Your Workflow. Get a real-time feed of all ROQUEFORT THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ROQUEFORT THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ROQUEFORT THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
